FundingWatcher
Home / Startups / By venture fund / F-Prime portfolio companies

F-Prime portfolio companies

Updated 16 Nov 2026

http://www.fprimecapital.com

F-Prime portfolio companies
One-time CSV
  • 75 funded companies, 72 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-investor-f-prime-capital-partners.csv75 rows × 18 columns
CompanyCityLast roundAmountDate
Insilico MedicineCambridgeSeries E$123.0M2025-03-13
Albert InventOaklandSeries B$55.0M2026-10-13
T-TherapeuticsCambridgeSeries B$133.0M2026-11-05
Avalyn PharmaSeattleSeries D$100.0M2025-07-22
TraceLinkNorth ReadingSeries D$93.0M2018-08-21
Canary TechnologiesSan FranciscoSeries D$80.0M2025-06-12
Xaira TherapeuticsSouth San FranciscoSeries A$1.0B2024-04-23
LighthouseLondonSeries C$370.0M2024-11-21

8 rows of the CSV in 5 of its 18 columns.

75
Startups
$7.7B
Total raised
4
Funded in the last 12 months
$221.5M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 75
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
Albert Invent Albert Invent builds an AI platform that supports chemistry research and development for scientific and industrial users. Artificial intelligence Oakland, United States Series B $55.0M 2026-10-13 $105.0M Index Ventures, F-Prime, Homebrew 101 to 250 2022
Immuneel Therapeutics Immuneel Therapeutics develops cell and gene therapies to treat cancer. Health care Bangalore, India Series B $10.5M 2026-06-08 $37.6M Eight Roads Ventures, F-Prime, True North 51 to 100 2018
Nocion Therapeutics Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. Biotech Cambridge, United States Series B $23.0M 2026-01-07 $134.0M Canaan Partners, F-Prime, OUP (Osage University Partners) +2 11 to 50 2017
Dispatch Dispatch helps independent financial advisors build their own firms through strategic investments and technology. Fintech Miami, United States Series A $18.0M 2025-09-04 $32.9M Great Oaks Venture Capital, F-Prime, Fika Ventures +1 11 to 50 2022
Avalyn Pharma Avalyn Pharma develops therapies for idiopathic pulmonary fibrosis and other respiratory diseases. Biotech Seattle, United States Series D $100.0M 2025-07-22 $372.5M Eight Roads Ventures, F-Prime, Wellington Management +2 11 to 50 2011
Canary Technologies Canary Technologies provides a digital guest management platform for hotels covering check-in, messaging, payments, and upsells. Artificial intelligence San Francisco, United States Series D $80.0M 2025-06-12 $177.0M Y Combinator, Insight Partners, Pioneer Fund +2 251 to 500 2017
Toku Toku automates payment collection for companies in Latin America through its payment relationship management platform. Fintech Santiago, Chile Series A $48.0M 2025-04-17 $66.5M Y Combinator, Pareto Holdings, F-Prime +1 101 to 250 2020
Insilico Medicine Insilico Medicine develops an AI platform for drug development targeting cancer and age-related diseases. Artificial intelligence Cambridge, United States Series E $123.0M 2025-03-13 $624.3M Qiming Venture Partners, F-Prime, Warburg Pincus +1 101 to 250 2014
1Money Network Technologies 1Money Network Technologies operates a payment network that lets users transfer money. Fintech Hamilton, Bermuda Seed $20.0M 2025-01-15 $20.0M F-Prime, Borderless Capital, Tribe Capital +1 11 to 50 2024
Rhygaze Rhygaze develops a gene therapy that targets cone cells to restore vision in blinding diseases. Biotech Basel, Switzerland Series A $86.0M 2025-01-10 $97.3M Google Ventures, F-Prime, ARCH Venture Partners +2 11 to 50 2024
Lighthouse Unicorn Lighthouse provides a commercial platform for the travel and hospitality industry. Software London, United Kingdom Series C $370.0M 2024-11-21 $470.0M Eight Roads Ventures, F-Prime, Venrex +2 501 to 1,000 2012
Mozper Mozper provides a debit card and money app that helps families manage their finances. Fintech Mexico City, Mexico Seed $979K 2024-09-30 Y Combinator, Foundation Capital, F-Prime +2 11 to 50 2019
Whatfix Whatfix provides GenAI-powered in-app guidance, simulated training, and analytics to help users adopt digital tools. Education Bangalore, India Series E $125.0M 2024-09-25 $264.8M Sequoia Capital, Peak XV Partners, F-Prime +2 501 to 1,000 2014
Shinobi Therapeutics Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment. Biotech South San Francisco, United States Series A $68.0M 2024-08-06 $178.0M Mitsubishi UFJ Capital, F-Prime, EQT Life Sciences +2 11 to 50 2023
Odaseva Odaseva provides data security and management solutions for enterprises running on Salesforce. Cybersecurity San Francisco, United States Series C $54.0M 2024-06-27 $93.0M Salesforce Ventures, Partech, Eight Roads Ventures +2 101 to 250 2012
Quantum Circuits Quantum Circuits is building a full-stack quantum computer based on dual-rail qubits. Hardware New Haven, United States Series B $60.0M 2024-05-01 $78.0M Sequoia Capital, F-Prime, IQT +2 51 to 100 2015
Xaira Therapeutics Unicorn Xaira Therapeutics applies artificial intelligence to drug discovery and biotechnology research. Artificial intelligence South San Francisco, United States Series A $1.0B 2024-04-23 $1.0B Sequoia Capital, New Enterprise Associates, Menlo Ventures +2 101 to 250 2023
Comanche Biopharma Comanche Biopharma works to make pregnancies around the world safer. Biotech Concord, United States Series B $75.0M 2024-01-17 $111.1M New Enterprise Associates, Google Ventures, F-Prime +2 11 to 50 2020
Burro Burro builds autonomous mobile robots that work safely alongside people in outdoor agricultural and industrial settings. Hardware Philadelphia, United States Series B $24.0M 2024-01-09 $36.6M Everywhere Ventures, Village Capital, F-Prime +2 51 to 100 2017
Nvelop Therapeutics Nvelop Therapeutics develops genetic medicines for patients with severe genetic diseases. Biotech Cambridge, United States Seed $100.0M 2023-09-20 $100.0M F-Prime, Atlas Venture, 5AM Ventures +1 51 to 100 2022
Better Life Partners Better Life Partners provides medical and behavioral healthcare to help people recover from addiction. Health care Manchester, United States Series B $26.5M 2023-08-29 $38.2M Alumni Ventures, F-Prime, .406 Ventures +2 51 to 100 2018
Tradier Tradier provides developers, platform providers and investors with a trading platform and real-time APIs. Fintech Charlotte, United States Series B $24.6M 2023-04-13 $30.7M Eight Roads Ventures, F-Prime, Peak 6 +2 51 to 100 2012
Hone Hone provides management training to help high-growth companies develop their leaders. Education Encinitas, United States Series B $30.0M 2022-08-19 $52.4M Bossa Invest, Gaingels, F-Prime +2 51 to 100 2018
Logixboard Logixboard provides white-labeled customer experience software that helps logistics providers increase sales and retain customers. Software Seattle, United States Series B $32.0M 2022-01-26 $50.8M Techstars, Insight Partners, Liquid 2 Ventures +2 51 to 100 2016
Parrot Software Parrot Software helps restaurants move their systems to its own platform with modern tools like automated sales. Software Monterrey, Mexico Series A $9.5M 2022-01-10 Y Combinator, Alumni Ventures, F-Prime +1 51 to 100 2020
Notable Notable provides an AI platform for healthcare operations. Artificial intelligence San Mateo, United States Series B $100.0M 2021-11-03 $119.2M Greylock, 8VC, F-Prime +2 251 to 500 2017
Guros Guros enables companies to generate revenue from insurance offerings while boosting retention of their core business. Fintech Mexico City, Mexico Seed $5.8M 2021-07-28 F-Prime, Clocktower Technology Ventures, Magma Partners +2 51 to 100 2013
Castor Castor provides a cloud-based clinical data platform that organizes and manages clinical trial processes. Health care Amsterdam, The Netherlands Series B $45.0M 2021-07-14 $64.4M Eight Roads Ventures, F-Prime, Two Sigma Ventures +1 251 to 500 2012
Orient Speech Therapy Center Orient Speech Therapy Center operates Chinese speech and language therapy services. Education Shenzhen, China Series C $60.0M 2021-06-25 Eight Roads Ventures, Northern Light Venture Capital, F-Prime +2 1,001 to 5,000 2007

Table 1. F-Prime portfolio companies: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 75.

Largest rounds

Last 12 months
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
2 Albert Invent Albert Invent builds an AI platform that supports chemistry research and development for scientific and industrial users. Artificial intelligence Oakland, United States Series B $55.0M 2026-10-13 $105.0M Index Ventures, F-Prime, Homebrew 101 to 250 2022
3 Nocion Therapeutics Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. Biotech Cambridge, United States Series B $23.0M 2026-01-07 $134.0M Canaan Partners, F-Prime, OUP (Osage University Partners) +2 11 to 50 2017
4 Immuneel Therapeutics Immuneel Therapeutics develops cell and gene therapies to treat cancer. Health care Bangalore, India Series B $10.5M 2026-06-08 $37.6M Eight Roads Ventures, F-Prime, True North 51 to 100 2018

Table 2. F-Prime portfolio companies: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Eight Roads Ventures Venture capital firm London, United Kingdom 25 33% 1 Immuneel Therapeutics
2 Y Combinator Startup accelerator Mountain View, United States 10 13%
3 Sequoia Capital Venture capital firm Menlo Park, United States 5 7%
4 ARCH Venture Partners Venture capital firm Chicago, United States 5 7%
5 Gaingels Syndicate Burlington, United States 4 5%
6 Techstars Startup accelerator New York, United States 4 5%
7 Bessemer Venture Partners Venture capital firm San Francisco, United States 3 4%
8 Maverick Ventures Venture capital firm San Francisco, United States 3 4%
9 Alumni Ventures Angel group Manchester, United States 3 4%
10 Google Ventures Corporate venture arm San Francisco, United States 3 4%
11 Qiming Venture Partners Venture capital firm Shanghai, China 2 3%
12 Andera Partners Private equity firm Paris, France 2 3%
13 FirstMark Venture capital firm New York, United States 2 3%
14 Goldman Sachs Investment bank New York, United States 2 3%
15 Insight Partners Private equity firm New York, United States 2 3%

Table 3. F-Prime portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Software 51 68% $5.1B
Health care 31 41% $5.4B
Fintech 17 23% $640.7M
Biotech 16 21% $3.7B
Artificial intelligence 10 13% $2.3B
Hardware 6 8% $354.9M
Cybersecurity 5 7% $315.1M
Education 4 5% $322.9M
Commerce 1 1% $10.9M

Table 4. F-Prime portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Seed 9 12% $5.1M
Series A 19 25% $25.0M
Series B 26 35% $32.0M
Series C 11 15% $45.0M
Series D+ 10 13% $100.0M

Table 5. F-Prime portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United States 59 79%
China 4 5%
Mexico 3 4%
United Kingdom 2 3%
India 2 3%
Switzerland 2 3%
Chile 1 1%
Bermuda 1 1%
The Netherlands 1 1%

Table 6. F-Prime portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
San Francisco 8 11%
Boston 8 11%
New York 7 9%
Cambridge 6 8%
Seattle 2 3%
South San Francisco 2 3%
Bangalore 2 3%
Los Angeles 2 3%
Basel 2 3%
Salt Lake City 2 3%
Mexico City 2 3%
Oakland 1 1%

Table 7. F-Prime portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 25% $133.0M
October 2026 1 25% $55.0M
June 2026 1 25% $10.5M
January 2026 1 25% $23.0M

Table 8. F-Prime portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 4 5% $221.5M
2025 10 13% $857.0M
2024 16 21% $2.1B
2023 4 5% $260.9M
2022 9 12% $168.3M
2021 10 13% $341.7M

Table 9. F-Prime portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 5 7%
2020 to 2022 15 20%
2015 to 2019 23 31%
2010 to 2014 27 36%
Before 2010 5 7%

Table 10. F-Prime portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 7 9%
11 to 50 19 25%
51 to 100 24 32%
101 to 250 14 19%
251 to 500 6 8%
501 to 1,000 3 4%
1,001 to 5,000 2 3%

Table 11. F-Prime portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many F-Prime portfolio companies are on the list?
75, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 75 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

F-Prime portfolio companies: 75 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Portfolio companies by country

Portfolio companies by city

Other venture fund portfolios

Cite: FundingWatcher, 75 startups, 16 November 2026. https://fundingwatcher.com/startups/investor/f-prime-capital-partners/